Literature DB >> 4813243

GLC determination of ibuprofen ((plus or minus)-2-(p-isobutylphenyl)propionic acid) in plasma.

D G Kaiser, G J Vangiessen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4813243     DOI: 10.1002/jps.2600630208

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics of ibuprofen in man IV: absorption and disposition.

Authors:  J G Wagner; K S Albert; G J Szpunar; G F Lockwood
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

2.  The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Authors:  M A Young; L Aarons; S Toon
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  The excretion of ibuprofen by the horse - a preliminary report.

Authors:  J A Evans; M B Lambert; J Miller
Journal:  Br J Sports Med       Date:  1976-10       Impact factor: 13.800

4.  Measurement of plasma ibuprofen by gas chromatography-mass spectrometry.

Authors:  B A Way; T R Wilhite; C H Smith; M Landt
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 5.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

6.  Pharmacokinetics of 2-(p-methylallylaminophenyl) propionic acid, alminoprofene, in man after single and multiple oral doses.

Authors:  A Premel-Cabic; P Allain; L Pidhorz; G Streichenberger
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

7.  Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss.

Authors:  J W Marks; G G Bonorris; L J Schoenfield
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.